BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19284366)

  • 1. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion.
    Gallagher TQ; Derkay CS
    Expert Opin Pharmacother; 2009 Mar; 10(4):645-55. PubMed ID: 19284366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
    Bergler WF; Götte K
    Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease.
    Rabah R; Lancaster WD; Thomas R; Gregoire L
    Pediatr Dev Pathol; 2001; 4(1):68-72. PubMed ID: 11200493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological case of the month. Recurrent respiratory papillomatosis.
    Ray R; Debich-Spicer D; Borrego O; Gilbert-Barness E
    Arch Pediatr Adolesc Med; 1998 Apr; 152(4):407-8. PubMed ID: 9559722
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel treatments for recurrent respiratory papillomatosis.
    Armbruster C
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1139-48. PubMed ID: 12150707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent respiratory papillomatosis: pathogenesis to treatment.
    Lee JH; Smith RJ
    Curr Opin Otolaryngol Head Neck Surg; 2005 Dec; 13(6):354-9. PubMed ID: 16282764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis.
    McGlennen RC; Adams GL; Lewis CM; Faras AJ; Ostrow RS
    Head Neck; 1993; 15(6):504-12; discussion 512-3. PubMed ID: 8253557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of recurrent respiratory papillomatosis.
    Kimberlin DW
    Expert Opin Pharmacother; 2002 Aug; 3(8):1091-9. PubMed ID: 12150688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
    Coulombeau B; Nusa Naiman A; Ceruse P; Froehlich P
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):315-20. PubMed ID: 12741293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis.
    Tasca RA; McCormick M; Clarke RW
    Int J Pediatr Otorhinolaryngol; 2006 Jul; 70(7):1183-7. PubMed ID: 16414125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
    Dancey DR; Chamberlain DW; Krajden M; Palefsky J; Alberti PW; Downey GP
    Chest; 2000 Oct; 118(4):1210-4. PubMed ID: 11035700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cidofovir activity in infantile recurrent respiratory papillomatosis].
    Palomar Asenjo V; Palomar García V; Soteras Ollé J; Ruiz Giner A
    Acta Otorrinolaringol Esp; 2005 Jan; 56(1):22-4. PubMed ID: 15747720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.